1. Home
  2. KNDI vs QNCX Comparison

KNDI vs QNCX Comparison

Compare KNDI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.96

Market Cap

92.7M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNDI
QNCX
Founded
2002
2012
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
139.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KNDI
QNCX
Price
$0.96
$4.02
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
101.8K
1.1M
Earning Date
11-19-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$104,035,613.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$0.72
52 Week High
$1.81
$4.30

Technical Indicators

Market Signals
Indicator
KNDI
QNCX
Relative Strength Index (RSI) 38.06 80.98
Support Level $0.89 $2.92
Resistance Level $0.95 $3.73
Average True Range (ATR) 0.04 0.39
MACD 0.00 0.16
Stochastic Oscillator 46.43 88.93

Price Performance

Historical Comparison
KNDI
QNCX

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: